J Korean Diabetes.  2022 Dec;23(4):238-244. 10.4093/jkd.2022.23.4.238.

Prediction of Diabetic Neuropathy Using Machine Learning Techniques

• Hyun JK

• KMID: 2538093
• DOI: http://doi.org/10.4093/jkd.2022.23.4.238

Abstract

Peripheral polyneuropathy is one of the most common complications in patients with diabetes mellitus, and it results in neuropathic pain, falling tendency, and foot ulcers as well as sensory and motor impairments. Numerous risk factors for diabetic neuropathy had been revealed through statistical analysis; however, statistics draw population inferences and might not be suitable for providing realtime prediction for each patient in clinical practice. Machine learning techniques were developed to find any predictive patterns based on input data. Such strategies can help predict neuropathy in diabetic patients, enabling prevention or early treatment to increase quality of life in diabetic patients. This article summarizes recent studies concerning the prediction of diabetic neuropathy using machine learning techniques, and suggests approaches for useful translation of these methods in the medical field.

Keyword

Diabetic neuropathies; Machine learning; Risk factors; Statistics

Figure

• 

  Fig. 1. Comparison of the flow of analysis between machine learning and deep learning/artificial neural network algorithms.

Reference

1.Feldman EL., Callaghan BC., Pop-Busui R., Zochodne DW., Wright DE., Bennett DL, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019. 5:42.

2.Sloan G., Selvarajah D., Tesfaye S. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nat Rev Endocrinol. 2021. 17:400–20.

3.Jordan MI., Mitchell TM. Machine learning: trends, per-spectives, and prospects. Science. 2015. 349:255–60.

4.Miotto R., Wang F., Wang S., Jiang X., Dudley JT. Deep learning for healthcare: review, opportunities and chal-lenges. Brief Bioinform. 2018. 19:1236–46.

5.Shin DY., Lee B., Yoo WS., Park JW., Hyun JK. Prediction of diabetic sensorimotor polyneuropathy using machine learning techniques. J Clin Med. 2021. 10:4576.

6.Ryu YH., Kim SY., Kim TU., Lee SJ., Park SJ., Jung HY, et al. Prediction of poststroke depression based on the out-comes of machine learning algorithms. J Clin Med. 2022. 11:2264.

7.Kim S., Shin DY., Kim T., Lee S., Hyun JK., Park SM. En-hanced recognition of amputated wrist and hand move-ments by deep learning method using multimodal fusion of electromyography and electroencephalography. Sensors (Basel). 2022. 22:680.

8.Ahsan MM., Luna SA., Siddique Z. Machine-learning-based disease diagnosis: a comprehensive review. Healthcare (Basel). 2022. 10:541.

9.Puttagunta M., Ravi S. Medical image analysis based on deep learning approach. Multimed Tools Appl. 2021. 80:24365–98.

10.Bzdok D., Altman N., Krzywinski M. Statistics versus machine learning. Nat Methods. 2018. 15:233–4.

11.Smith H., Sweeting M., Morris T., Crowther MJ. A scoping methodological review of simulation studies comparing statistical and machine learning approaches to risk prediction for time-to-event data. Diagn Progn Res. 2022. 6:10.

12.Gulshan V., Peng L., Coram M., Stumpe MC., Wu D., Narayanaswamy A, et al. Development and validation of a deep learning algorithm for detection of diabetic retinopa-thy in retinal fundus photographs. JAMA. 2016. 316:2402–10.

13.U.S. Food & Drug Administration. Artificial intelligence and machine learning (AI/ML)-enabled medical devices. Available from: https://www.fda.gov/medical-de-vices/software-medical-device-samd/artificial-intelli-gence-and-machine-learning-aiml-enabled-medical-devices (updated 2022 Oct 5).

14.Muehlematter UJ., Daniore P., Vokinger KN. Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015-20): a comparative analysis. Lancet Digit Health. 2021. 3:e195–203.

15.Aisu N., Miyake M., Takeshita T., Akiyama M., Kawasaki R., Kashiwagi K, et al. Regulatory-approved deep learning/machine learning-based medical devices in Japan as of 2020: a systematic review. PLOS Digit Health. 2022. 1:e0000001.

16.Konam S. Where did IBM go wrong with Watson Health? Available from:. https://qz.com/2129025/where-did-ibm-go-wrong-with-watson-health. (updated 2022 Mar 2).

17.Kiseleva A., Kotzinos D., De Hert P. Transparency of AI in healthcare as a multilayered system of accountabilities: between legal requirements and technical limitations. Front Artif Intell. 2022. 5:879603.

18.Naik N., Hameed BMZ., Shetty DK., Swain D., Shah M., Paul R, et al. Legal and ethical consideration in artificial intelligence in healthcare: who takes responsibility? Front Surg. 2022. 9:862322.

19.Kazemi M., Moghimbeigi A., Kiani J., Mahjub H., Faradmal J. Diabetic peripheral neuropathy class prediction by multi-category support vector machine model: a cross-sectional study. Epidemiol Health. 2016. 38:e2016011.

20.Dagliati A., Marini S., Sacchi L., Cogni G., Teliti M., Tibollo V, et al. Machine learning methods to predict diabetes complications. J Diabetes Sci Technol. 2018. 12:295–302.

21.Fan Y., Long E., Cai L., Cao Q., Wu X., Tong R. Machine learning approaches to predict risks of diabetic complications and poor glycemic control in nonadherent type 2 diabetes. Front Pharmacol. 2021. 12:665951.

22.Maeda-Gutiérrez V., Galván-Tejada CE., Cruz M., Val-ladares-Salgado A., Galván-Tejada JI., Gamboa-Rosales H, et al. Distal symmetric polyneuropathy identification in type 2 diabetes subjects: a random forest approach. Healthcare (Basel). 2021. 9:138.

23.Dorfman E. How much data is required for machine learning? Available from:. https://postindustria.com/how-much-data-is-required-for-machine-learning/. (updated 2022 Mar 25).

24.Tesfaye S., Boulton AJ., Dyck PJ., Freeman R., Horowitz M., Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010. 33:2285–93. Erratum in: Diabetes Care 2010;33):2725.

25.Dyck PJ., Overland CJ., Low PA., Litchy WJ., Davies JL., Dyck PJ, et al. Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial. Muscle Nerve. 2010. 42:157–64.